Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 13
Submit an article Journal homepage
143
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity

Juehua Gaoa Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
,
Lucy Fua Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Xinyan Lua Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Madina Sukhanovaa Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Olga Frankfurtb Hematology and Oncology, Hematology Oncology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Arash Mohtashamianc Naval Medical Center San Diego, San Diego, CA, USA
,
Amy Chadburnd Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
,
Lawrence Jenningsa Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Barina Aqila Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Qing Chena Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
&
Yi-Hua Chena Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
 show all
Pages 3304-3307 | Received 12 Feb 2021, Accepted 20 Jun 2021, Published online: 14 Jul 2021

References

  • Horny HP, Ac Arber DA, Peterson LC, et al. Mastocytosis. In: Swerdlow SCE, Harris NL, Jaffe ES, Pileri SA, Stein HM, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4 ed. Lyon (France): International Agency for Research on Cancer; 2017. p 138–139.
  • Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012;122(10):3398–3406.
  • Grossmann V, Haferlach C, Weissmann S, et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosom Cancer. 2013;52(4):410–422.
  • You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol. 2015;144(3):411–422.
  • Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603–625.
  • Prebet T, Carbuccia N, Raslova H, et al. Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia. Eur J Haematol. 2013;91(3):277–279.
  • Skala SL, Lucas DR, Dewar R. Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med. 2018;142(11):1322–1329.
  • Stoecker MM, Wang E. Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies. Arch Pathol Lab Med. 2013;137(6):865–870.
  • Rausch T, Jones DT, Zapatka M, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell. 2012;148(1-2):59–71.
  • Bochtler T, Granzow M, Stolzel F, et al. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia. Blood. 2017;129(10):1333–1342.
  • Eischen CM. Genome stability requires p53. Cold Spring Harb Perspect Med. 2016;6(6):a026096.
  • Monnier J, Georgin-Lavialle S, Canioni D, et al. Mast cell sarcoma: new cases and literature review. Oncotarget. 2016;7(40):66299–66309.
  • Kim YS, Wu H, Pawlowska AB, et al. Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C > T) KIT mutation, mimicking histiocytic neoplasm. Am J Surg Pathol. 2013;37(3):453–458.
  • Georgin-Lavialle S, Aguilar C, Guieze R, et al. Mast cell sarcoma: a rare and aggressive entity-report of two cases and review of the literature. J Clin Oncol. 2013;31(6):e90–e97.
  • Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004;6(4):313–319.
  • Lee JW, Yoo NJ, Soung YH, et al. BRAF mutations in non-Hodgkin’s lymphoma. Br J Cancer. 2003;89(10):1958–1960.
  • Davidsson J, Lilljebjorn H, Panagopoulos I, et al. BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias. Leukemia. 2008;22(8):1619–1621.
  • Dankner M, Lajoie M, Moldoveanu D, et al. Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanomas. Clin Cancer Res. 2018;24(24):6483–6494.
  • Molnar E, Rittler D, Baranyi M, et al. Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells. BMC Cancer. 2018;18(1):542.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.